Study Stopped
Recruitment for phase 1 is completed, waiting for phase 2
Determinants of Cardiovascular Disease Risk Factors Among Youth With Type 1 Diabetes
CARDEA
Early Myocardial Morphologic and Functional Changes and Their Association With Diet and Physical Activity in Adolescents With Type 1 Diabetes
3 other identifiers
observational
600
1 country
1
Brief Summary
Type 1 diabetes mellitus (T1D) is the most common form of diabetes among children and youth, and it is increasing around the world, particularly among children under 5 years. This is worrisome given the chronic nature of the disease and its strong association with an increased risk of cardiovascular disease (CVD). Evidence suggests that markers of CVD are already present in children with T1D, making prevention a clinical and public health priority in this high-risk population. Despite this, a good understanding of what factors predispose children with T1D to CVD is still lacking. Our study aims to better understand in this population what individual, familial and environmental characteristics increase the risk for heart disease, how to best measure it early on and what are the potential mechanisms underlying the heightened risk for heart disease in youth with T1D. Specifically, we aim to:
- 1.compare established risk factors (dyslipidemia, hypertension) with novel early markers for CVD (cardiac phenotype, arterial stiffness, endothelial function) in adolescents with T1D and healthy controls;
- 2.examine the associations between these novel early markers with: i) lifestyle habits; ii) measures of inflammation; and iii) markers of oxidative stress among adolescents with T1D and healthy controls, and determine group differences in these associations;
- 3.explore, across both groups, the associations between these established and novel early markers of CVD with neighborhood features.
- 4.Determine sex and gender differences in novel markers of CVD (cardiac structure/myocardial oxygenation, vascular studies including endothelial function and arterial stiffness) in youth with T1D and healthy controls;
- 5.Determine, across both groups, sex and gender differences in associations between markers of CVD and lifestyle habits, specifically: i) moderate-to-vigorous physical activity (MVPA); ii) dietary intake (carbohydrates, sugar, saturated/trans-fat, fiber, food groups); iii) sedentary behavior; and iv) sleep;
- 6.Measure changes in novel markers of CVD from adolescence to early adulthood among individuals with T1D and healthy controls;
- 7.Assess whether lifestyle habits in adolescence are prospectively associated with established (dyslipidemia, hypertension) and novel (cardiac structure/myocardial oxygenation, endothelial function, arterial stiffness) markers of CVD in early adulthood, and if these associations differ according to T1D status, adiposity, sex and gender.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 12, 2017
CompletedFirst Submitted
Initial submission to the registry
February 27, 2020
CompletedFirst Posted
Study publicly available on registry
March 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
December 3, 2024
November 1, 2024
14 years
February 27, 2020
November 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Cardiac structure (MRI)
Baseline measurement
Endothelial function (Flow-mediated dilation)
Baseline measurement
Vascular structure (Pulse-wave velocity)
Baseline measurement
Secondary Outcomes (2)
Dyslipidemia
Baseline measurement
Hypertension
Baseline measurement
Study Arms (2)
Diabetics
Girls and boys living with Type 1 Diabetes.
Control
Age and sex matched participants without any type of diabetes
Eligibility Criteria
T1D group: Sainte-Justine Hospital's Diabetes Clinic patients Control group: Community sample
You may qualify if:
- Diagnosis of T1D (for the T1D group) or no diagnosis of any type of diabetes (for the control group)
- to 18 years old
You may not qualify if:
- Youth with another type of diabetes such as T2D
- Conditions that could limit their ability to participate in the study
- Known pathology that would influence their risk for CVD
- Siblings of a participant already enrolled in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Sainte-Justine
Montreal, Quebec, H3T 1C5, Canada
Related Publications (1)
Henderson M, Friedrich M, Van Hulst A, Pelletier C, Barnett TA, Benedetti A, Bigras JL, Drapeau V, Lavoie JC, Levy E, Mathieu ME, Nuyt AM. CARDEA study protocol: investigating early markers of cardiovascular disease and their association with lifestyle habits, inflammation and oxidative stress in adolescence using a cross-sectional comparison of adolescents with type 1 diabetes and healthy controls. BMJ Open. 2021 Sep 8;11(9):e046585. doi: 10.1136/bmjopen-2020-046585.
PMID: 34497076DERIVED
Biospecimen
Plasma, serum, whole blood, urine, feces
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mélanie Henderson, MD, Ph.D
St. Justine's Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor, Pediatrics
Study Record Dates
First Submitted
February 27, 2020
First Posted
March 11, 2020
Study Start
January 12, 2017
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2030
Last Updated
December 3, 2024
Record last verified: 2024-11